Omega Diagnostics Group PLC
LSE:ODX
Intrinsic Value
Omega Diagnostics Group Plc is a holding company, which engages in the manufacture, development, and distribution of medical diagnostics products. [ Read More ]
The intrinsic value of one
ODX
stock under the Base Case scenario is
3.84
GBX.
Compared to the current market price of 2.2 GBX,
Omega Diagnostics Group PLC
is
Undervalued by 43%.
Omega Diagnostics Group PLC's market capitalization is 5.2m GBX.
ODX stock price is 2.2 GBX.
ODX stock price (2.2 GBX) is 43% less than its Intrinsic Value (3.84 GBX).
ODX. Open DCF Valuation
ODX has upside potential of 355% compared to the average analyst price target.
Open Wall St Estimates
ODX's Revenue has grown by 8% over the past 12 months.
ODX has negative Operating Income for the last twelve months.
ODX's Revenue has been falling by 8% per year for the last 3 years.
ODX's ROE (Return on Equity) has significantly decreased in the last 3 years from -11% to -35%, and is approaching profitability.
ODX's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 2% to -25%.
ODX has negative three-year average ROIC (Return on Invested Capital): -1%. The company is not efficient at using invested capital to generate operating income.
ODX has negative Net Income for the last twelve months.
ODX's ROE (Return on Equity) for the past 12 months is negative and is equal to -35%.
ODX's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -25%.
ODX has positive Gross Profit for the last twelve months.
ODX has negative Free Cash Flow for the last twelve months.
ODX's long-term assets (14m GBP) exceed its long-term liabilties (4m GBP).
ODX's D/E (Debt to Equity) is very low and is equal to 0.
ODX has negative three-year average ROE (Return on Equity): -39%. The company is not efficient at transforming stockholders' equity into net income.
ODX's short-term assets (8m GBP) exceed its short-term liabilties (2m GBP).
ODX has negative Net Debt. This means that the company has more cash and short-term investments (5m GBP) than debt (19k GBP).
ODX's Altman Z-Score is very low and is equal to -1.43.
ODX doesn't generate enough operating income (-3m GBP) to safely cover interest payments on its debt (10k GBP).
Valuation Backtest
Omega Diagnostics Group PLC
Run backtest to discover the historical profit from buying and selling
ODX
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Omega Diagnostics Group PLC
Balance Sheet Decomposition
Omega Diagnostics Group PLC
| Current Assets | 8.3m |
| Cash & Short-Term Investments | 5.1m |
| Receivables | 2.4m |
| Other Current Assets | 777k |
| Non-Current Assets | 6.1m |
| PP&E | 588k |
| Intangibles | 4.5m |
| Other Non-Current Assets | 997k |
| Current Liabilities | 1.6m |
| Accounts Payable | 1.5m |
| Other Current Liabilities | 55k |
| Non-Current Liabilities | 2.9m |
| Long-Term Debt | 19k |
| Other Non-Current Liabilities | 2.9m |
Earnings Waterfall
Omega Diagnostics Group PLC
|
Revenue
|
7.5m
GBP
|
|
Cost of Revenue
|
-4m
GBP
|
|
Gross Profit
|
3.5m
GBP
|
|
Operating Expenses
|
-6.3m
GBP
|
|
Operating Income
|
-2.7m
GBP
|
|
Other Expenses
|
-1.1m
GBP
|
|
Net Income
|
-3.9m
GBP
|
Free Cash Flow Analysis
Omega Diagnostics Group PLC
ODX Profitability Score
Profitability Due Diligence
Omega Diagnostics Group PLC's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
Omega Diagnostics Group PLC's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
ODX Solvency Score
Solvency Due Diligence
Omega Diagnostics Group PLC's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Score
Omega Diagnostics Group PLC's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ODX Price Targets Summary
Omega Diagnostics Group PLC
According to Wall Street analysts, the average 1-year price target for
ODX
is 10 GBX
.
Shareholder Return
ODX Price
Omega Diagnostics Group PLC
| Average Annual Return | 96.33% |
| Standard Deviation of Annual Returns | 202.73% |
| Max Drawdown | -98% |
| Market Capitalization | 5.2m GBX |
| Shares Outstanding | 237 685 200 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Omega Diagnostics Group PLC
Country
Industry
Market Cap
Dividend Yield
Description
Omega Diagnostics Group Plc is a holding company, which engages in the manufacture, development, and distribution of medical diagnostics products. The company is headquartered in Alva, Stirlingshire and currently employs 171 full-time employees. The company went IPO on 2004-03-18. The principal activities of the Company and its subsidiaries are the manufacture, development and distribution of medical diagnostics products. The firm operates through two segments: Health and Nutrition and Global Health. The Health and Nutrition segment specializes in the research, development and production of kits to aid the detection of immune reactions to food. The company also provides clinical analysis to the general public, clinics and health professionals as well as supplying the consumer Food Detective test. The Global Health segment specializes in the research, development, production and marketing of kits to aid the diagnosis of infectious diseases, including COVID-19. The firm's products include FoodPrint, Food Detective, CNS lab, VISITECT CD4 Advanced Disease, VISITECT COVID-19 IgM/IgA/IgG and VISITECT COVID-19 Antigen.
Contact
IPO
Employees
Officers
The intrinsic value of one
ODX
stock under the Base Case scenario is
3.84
GBX.
Compared to the current market price of 2.2 GBX,
Omega Diagnostics Group PLC
is
Undervalued by 43%.
You don't have any saved screeners yet
